Physician profile
Mary E Dial
NPI 1962468553
$2,558.15
in general payments reported to CMS, 2019-2025
17 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,069 · 2020: $201 · 2021: $129 · 2022: $135 · 2023: $818 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,023.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $543.54 | 2019-2025 | Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $427.05 | 2019-2022 | |
| Edwards Lifesciences Corporation | $405.93 | 2021-2025 | Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $261.94 | 2019 | |
| Glaxosmithkline, LLC. | $180.93 | 2019-2023 | Arexvy, Shingrix |
| Otsuka America Pharmaceutical, INC. | $125.29 | 2023 | Rexulti |
| Neurent Medical Limited | $125.00 | 2023 | Neuromark Radiofrequency Console, Neuromark Device |
| Pfizer INC. | $111.82 | 2019-2023 | |
| Amgen INC. | $75.97 | 2019-2020 | |
| Astellas Pharma US INC | $72.11 | 2019-2020 | |
| Therapeuticsmd, INC. | $65.66 | 2019 | |
| Lilly USA, LLC | $47.73 | 2019 | |
| Novartis Pharmaceuticals Corporation | $38.32 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $24.44 | 2019 | |
| Sanofi Pasteur INC. | $20.46 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $20.18 | 2019 | |
| Merck Sharp & Dohme LLC | $11.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Dial listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.